Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Ag10 Hydrochloride
2. Ag-10 Hydrochloride
3. Alxn2060 Hydrochloride
4. Acoramidis (hydrochloride)
5. Alxn-2060 Hydrochloride
6. Vy9c88c2nv
7. Acoramidis Hydrochloride [usan]
8. 2242751-53-5
9. Benzoic Acid, 3-(3-(3,5-dimethyl-1h-pyrazol-4-yl)propoxy)-4-fluoro-, Hydrochloride (1:1)
10. Unii-vy9c88c2nv
11. Chembl4650226
12. Schembl20475239
13. Acoramidis Hydrochloride [jan]
14. Hy-109165a
15. Cs-0143619
16. 3-(3-(3-5-dimethyl-1h-pyrazol-4-yl)propoxy)-4-fluorobenzoic Acid Hydrochloride
| Molecular Weight | 328.76 g/mol |
|---|---|
| Molecular Formula | C15H18ClFN2O3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 328.0989983 g/mol |
| Monoisotopic Mass | 328.0989983 g/mol |
| Topological Polar Surface Area | 75.2 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 356 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
50
PharmaCompass offers a list of Acoramidis Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Acoramidis Hydrochloride manufacturer or Acoramidis Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Acoramidis Hydrochloride manufacturer or Acoramidis Hydrochloride supplier.
A Acoramidis manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Acoramidis, including repackagers and relabelers. The FDA regulates Acoramidis manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Acoramidis API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Acoramidis manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Acoramidis supplier is an individual or a company that provides Acoramidis active pharmaceutical ingredient (API) or Acoramidis finished formulations upon request. The Acoramidis suppliers may include Acoramidis API manufacturers, exporters, distributors and traders.
click here to find a list of Acoramidis suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Acoramidis as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Acoramidis API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Acoramidis as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Acoramidis and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Acoramidis NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Acoramidis suppliers with NDC on PharmaCompass.
Acoramidis Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Acoramidis GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Acoramidis GMP manufacturer or Acoramidis GMP API supplier for your needs.
A Acoramidis CoA (Certificate of Analysis) is a formal document that attests to Acoramidis's compliance with Acoramidis specifications and serves as a tool for batch-level quality control.
Acoramidis CoA mostly includes findings from lab analyses of a specific batch. For each Acoramidis CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Acoramidis may be tested according to a variety of international standards, such as European Pharmacopoeia (Acoramidis EP), Acoramidis JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Acoramidis USP).